David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 11,147 shares at $1.63 ($18K) on 2018-11-05, disclosed to the SEC on 2018-11-07.
Scheduled sale ($18k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.63 | 94 | $153 | 0.8% |
| 2 | $1.63 | 204 | $333 | 1.8% |
| 3 | $1.63 | 2,842 | $5K | 25.4% |
| 4 | $1.64 | 240 | $394 | 2.2% |
| 5 | $1.64 | 521 | $854 | 4.7% |
| 6 | $1.64 | 7,246 |
| $12K |
| 65.1% |
| Total | $1.64 avg | 11,147 | $18K | 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |